PD-L1 anticorps (AA 19-238) (APC)
Aperçu rapide pour PD-L1 anticorps (AA 19-238) (APC) (ABIN2224682)
Antigène
Voir toutes PD-L1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 19-238
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- CD274 (B7-h1 Protein, B7-H1, B7H1, MGC142294, MGC142296, PD-L1, PDCD1L1, PDCD1LG1, PDL1) (APC)
-
Purification
- Purified by Protein G affinity chromatography.
-
Immunogène
- Recombinant protein corresponding to aa19-238 of human B7-H1, NSO-derived (Q9NZQ7).
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in saline, 0.5 % BSA, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- 4°C ,Do Not Freeze
-
-
- PD-L1 (CD274 (PD-L1))
-
Autre désignation
- CD274
-
UniProt
- Q9NZQ7
-
Pathways
- Cancer Immune Checkpoints
Antigène
-